A A A

Current review panels

Review panels are composed for specific competitions and membership will depend on the expertise needed. Please select the appropriate competition for current information on panel composition.

Note:

For competitions with an LOI stage - panels may be reduced between stages depending on expertise required to review the full applications. Panel members participating in the LOI review only will be marked with an *.

For competitions with multiple panels – applicants indicate their panel recommendation, however, final panel selection will be determined by the panel chairs and CCSRI based on the panel with the most appropriate expertise.

Innovation Grant and Innovation to Impact Grant panels

I1a - Biomarkers and Genomics

Including genomics, proteomics, metabolomics (and other ‘omics’), high-throughput sequencing, bioinformatics, diagnostic, prognostic and predictive biomarkers, circulating tumour cells.

Panel meeting: June 10, 2016

Harriet Feilotter, PhD (Chair) Queen’s University
Kingston, ON
Philip Awadalla, PhD Ontario Institute for Cancer Research
Toronto, ON
Jane Bayani, PhD Ontario Institute for Cancer Research
Toronto, ON
Nicolas Crapoulet, PhD
Atlantic Cancer Research Institute
Moncton, NB
Robert Day, PhD  University of Sherbrooke
Sherbrooke, QC
Josee Dostie, PhD McGill University
Montreal, QC
Nathalie Johnson, MD/PhD  Lady Davis Institute
Montreal, QC
Bryan Lo, MD/PhD Ottawa General Hospital
Ottawa, ON
Julian Lum, PhD  BC Cancer Agency
Vancouver, BC
John D. McPherson, PhD University of California Davis
Sacramento, CA 
Leigh Murphy, PhD
Manitoba Institute of Cell Biology
Winnipeg, MB
Raymond Ng, PhD University of British Columbia
Vancouver, BC
Robert Sladek, MD McGill University
Montreal, QC
George Yousef, MD/PhD St Michael’s Hospital
Toronto, ON
Steve Bilodeau, PhD (Scientific Officer) Centre Hospitalier Universitaire de Quebec (CHUQ)
Quebec City, QC
Troy Harkness, PhD (Scientific Officer) University of Saskatchewan
Saskatoon, SK
Shayenne Herder (Community Representative) Canadian Cancer Society - Alberta/NWT Division 
Sean Nurmsoo (Community Representative) Canadian Cancer Society - Nova Scotia Division

 

I1b - Gene Regulation & Cell Biology

Including mechanisms of transcriptional control, epigenetics, chromatin structure and function, translational control, RNA biology, post-translational modifications, telomere function, DNA damage and repair, organellar biology, model organisms, angiogenesis, cell migration, cell invasion, tumour environment.

Panel meeting: June 8, 2016

John White, PhD (Chair) McGill University
Montreal, QC
Kristin Baetz, PhD University of Ottawa
Ottawa, ON
Peter Black, MD University of British Columbia
Vancouver, BC
Peter Cheung, PhD York University
Toronto, ON
Martin Hirst, PhD
BC Cancer Agency
Vancouver, BC
Benjamin Kwok, PhD Institute for Research in Immunology and Cancer (IRIC)
Montreal, QC
C Jane McGlade, PhD The Hospital for Sick Children
Toronto, ON
Lawrence McIntosh, PhD
University of British Columbia
Vancouver, BC
Helen McNeill, PhD
Mount Sinai Hospital
Toronto, ON
Janusz Rak, MD/PhD Research Institute of the McGill University Health Centre
Montreal, QC
Brian Raught, PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
Frank Sicheri, PhD Mount Sinai Hospital
Toronto, ON
Uri Tabori, MD The Hospital for Sick Children
Toronto, ON
Ivan Topisirovic, PhD
Jewish General Hospital
Montreal, QC
Michael Downey, PhD (Scientific Officer) University of Ottawa
Ottawa, ON 
Peter Stirling, PhD (Scientific Officer) BC Cancer Agency
Vancouver, BC
Kathryn Dickinson (Community Representative) Canadian Cancer Society - Ontario Division
Tania Loftsgard (Community Representative) Canadian Cancer Society - Alberta/NWT Division

 

I2 - Imaging and Technology Development

Including platform and tool development, systems biology, magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound, computer tomography (CT), radiobiology, radiotherapy, photodynamic therapy (PDT), optical imaging, microfluidics, nanotechnology.

Panel meeting: June 1, 2016

Warren Chan, PhD (Chair) University of Toronto
Toronto, ON
Weibo Cai, PhD University of Wisconsin 
Madison, WI
Aaron Fenster, PhD  Robarts Research Institute
London, ON
Paula Foster, PhD Robarts Research Institute
London, ON
Richard Frayne, PhD University of Calgary
Calgary, AB
Betty Kim, MD/PhD Mayo Clinic
Jacksonville, FL
Marianna Koritzinsky, PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
Stephen Lam, MD  BC Cancer Agency
Vancouver, BC 
Frédéric Leblond, PhD  Ecole Polytechnique de Montreal
Montreal, QC
Jonathan Lovell, PhD University a Buffalo
Buffalo, NY
Cynthia Menard, MD Centre Hospitalier de l’Universite de Montreal
Montreal, QC
Shiladitya Sengupta, PhD Brigham and Women's Hospital
Cambridge, MA
Haishan Zeng, PhD BC Cancer Agency
Vancouver, BC
Rebecca Thornhill, PhD (Scientific Officer) University of Ottawa
Ottawa, ON
Aaron Ward, PhD (Scientific Officer) London Health Sciences Centre
London, ON
Justin Arcaro (Community Representative) Canadian Cancer Society - Ontario Division
Genevieve Roussy (Community Representative) Canadian Cancer Society - New Brunswick Division

 

I3 - Immunology, Signalling and Stem Cells

Including metastasis, hormone-sensitive pathways, growth-factor mediated signalling, immunotherapies, viral therapeutics, cancer stem cells, signal transduction, innate immunity and infection, tumour antigens, immune surveillance, hematopoiesis.

Panel meeting: June 3, 2016

Ben Alman, MD (Chair) Duke University
Durham, NC
Laurie Ailles, PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
David Evans, PhD University of Alberta
Edmonton, AB
Norman Iscove, MD/PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
Sam Kung, PhD University of Manitoba
Winnipeg, MB
Andrew Makrigiannis, PhD Dalhousie University
Halifax, NS
Jean Marshall, PhD Dalhousie University
Halifax, NS
Mark Minden, MD/PhD  Princess Margaret Cancer Centre - UHN
Toronto, ON
William Muller, PhD McGill University
Montreal, QC
Luc Sabourin, PhD Ottawa Hospital Research Institute
Ottawa, ON
Subash Sad, PhD University of Ottawa
Ottawa, ON 
Sheila Singh, MD/PhD McMaster University
Hamilton, ON
Heather Melichar, PhD (Scientific Officer) Hopital Maisonneuve-Rosemont
Montreal, QC
Patrick O’Donoghue, PhD (Scientific Officer) Western University
London, ON
Mili Baghela (Community Representative) Canadian Cancer Society - Ontario Division
Teresa Bell (Community Representative)
Canadian Cancer Society - Ontario Division

 

I4 - Novel Therapeutics

Including drug candidates, rational drug design, hit and target validation, compound screening, medicinal chemistry, pharmacology, drug delivery systems, drug transport, drug resistance, combination therapies and pharmacogenomics.

Panel meeting: June 9, 2016

Craig Thomas, PhD (Chair) National Institutes of Health
Rockville, MD
Robert Britton, PhD Simon Fraser University
Burnaby, BC
Daniel De Carvalho, PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
Mark Glover, PhD University of Alberta
Edmonton, AB
Philip Hieter, PhD University of British Columbia
Vancouver, BC
Fei-Fei Liu, MD Princess Margaret Cancer Centre - UHN
Toronto, ON
Ian Lorimer, PhD Ottawa Hospital Research Institute
Ottawa, ON 
Kevin Petrecca, MD/PhD  McGill University
Montreal, QC 
Lynne-Marie Postovit, PhD  University of Alberta
Edmonton, AB
Jason Rohde, PhD National Institutes of Health
Rockville, MD
Rodger Tiedemann, MD/PhD Princess Margaret Cancer Centre - UHN
Toronto, ON
Josie Ursini-Siegel, PhD Lady Davis Institute
Montreal, QC
Murray Webb, PhD The Centre for Drug Research and Development (CDRD)
Vancouver, BC
Alexander Yakunin, PhD University of Toronto
Toronto, ON
Amina Zoubeidi, PhD University of British Columbia
Vancouver, BC
Daniel Schramek, PhD (Scientific Officer) Mount Sinai Hospital
Toronto, ON
George Zogopoulos, MD/PhD (Scientific Officer)
McGill University Health Centre
Montreal, QC
Joel Finlay (Community Representative)
Canadian Cancer Society - British Columbia/Yukon Division
Tanya Gallant (Community Representative)
Canadian Cancer Society - Prince Edward Island Division

 

I5 - Prevention and Quality of Life 

Including epidemiology, prevention interventions, lifestyle and environmental risk factors, health economics, health services, quality of life, survivorship, palliative care, psychosocial issues, knowledge translation and exchange.

Panel meeting: June 2, 2016

Patricia Parker, PhD (Chair) Memorial Sloan-Kettering Cancer Center
New York, NY
Michelle Janelsins, PhD  University of Rochester
Rochester, NY
Igor Karp, PhD Western University
London, ON
Karen Kopciuk, PhD  Alberta Health Services
Calgary, AB 
Robert Reid, PhD/MBA University of Ottawa Heart Institute
Ottawa, ON
Catherine Sabiston, PhD University of Toronto
Toronto, ON
Jonathan Sussman, MD Juravinski Cancer Centre
Hamilton, ON
Thomas Tenkate, PhD Ryerson University
Toronto, ON
Alice Wei, MD  Princess Margaret Cancer Centre - UHN
Toronto, ON
Darren Brenner, PhD (Scientific Officer) Alberta Health Services
Calgary, AB
Jennifer Brunet, PhD (Scientific Officer) University of Ottawa
Ottawa, ON
Arshia Beigi (Community Representative)
Canadian Cancer Society - British Columbia/Yukon Division
Matt Creighton (Community Representative)
Canadian Cancer Society - Alberta/NWT Division

 

Impact Grant panel

LOI review teleconference: June 17, 2016

Panel meeting: November 21, 2016

Craig Earle, MD (Co-Chair) Sunnybrook Research Institute
Toronto, ON 
Jim Woodgett, PhD (Co-Chair) Mount Sinai Hospital
Toronto, ON
Samuel Aparicio, PhD BC Cancer Agency
Vancouver, BC
Harold Atkins, MD Ottawa Hospital Research Institute
Ottawa, ON
Jason Berman, MD IWK-Grace Health Centre
Halifax, NS
Mick Bhatia, PhD McMaster University
Hamilton, ON
Deborah Bowen, PhD University of Washington
Seattle, WA
Grant Brown, PhD University of Toronto
Toronto, ON
Andrew Craig, PhD Queen’s University
Kingston, ON
Shoukat Dedhar, PhD BC Cancer Agency
Vancouver, BC
Mary Jane Esplen, PhD/RN Princess Margaret Cancer Centre – UHN
Toronto, ON
Steven Gallinger, MD  Mount Sinai Hospital
Toronto, ON 
Peter Greer, PhD  Queen's University
Kingston, ON 
Trang Hoang, PhD IRIC
Montreal, QC
Nada Jabado, MD/PhD McGill University
Montreal, QC
Rama Khokha, PhD  Princess Margaret Cancer Centre – UHN
Toronto, ON 
Robert Korneluk, PhD Children’s Hospital of Eastern Ontario
Ottawa, ON
Nathalie Labrecque, PhD University of Montreal
Montreal, QC
Claude Perreault, MD  IRIC
Montreal, QC 
Geoff Porter, MD Dalhousie University
Halifax, NS
Poul Sorensen, MD/PhD BC Cancer Agency
Vancouver, BC
Lillian Sung, MD/PhD The Hospital for Sick Children
Toronto, ON
Bradly Wouters, PhD Princess Margaret Cancer Centre – UHN
Toronto, ON
Jeffrey Wrana, PhD Mount Sinai Hospital
Toronto, ON
Li Zhang, MD/PhD Toronto General Hospital – UHN
Toronto, ON

Prevention Research Grant panel

LOI review teleconference: April 4, 2016

Panel meeting: September 26, 2016

Eduardo Franco, MPH/PhD(Chair)  McGill University
Montreal, QC
Irene Andrulis, PhD  Mount Sinai Hospital
Toronto, ON 
Sunday Azagba, PhD University of Waterloo
Waterloo, ON
Louise Brinton, PhD/MPH National Cancer Institute
Rockville, MD
Michael Chaiton, PhD University of Toronto
Toronto, ON
Claire de Oliveira, PhD Centre for Addiction and Mental Health
Toronto, ON
Walter Gotlieb, MD/PhD  Jewish General Hospital
Montreal, QC 
Emmanuel Guindon, PhD McMaster University
Hamilton, ON
Melissa Henry, PhD Jewish General Hospital
Montreal, QC
Nancy Kreiger, MPH/PhD/FACE University of Toronto
Toronto, ON
Anthony Miller, MD/FACE University of Toronto
Toronto, ON
Lisa Mirabello, PhD National Cancer Institute
Rockville, MD
Jennifer O'Loughlin, PhD CRCHUM, University of Montreal
Montreal, QC
Lawrence Paszat, MD University of Toronto
Toronto, ON
Harriet Richardson, PhD Queen’s University
Kingston, BC
Beti Thompson, PhD Fred Hutchinson Cancer Research Center
Seattle, WA
Amy Yaroch, PhD Gretchen Swanson Center for Nutrition
Omaha, NE
Regina Ziegler, PhD/MPH National Cancer Institute
Rockville, MD 
Geetanjali Datta, PhD (Scientific Officer) University of Montreal
Montreal, QC 
Leia Minaker, PhD (Scientific Officer) University of Waterloo
Waterloo, ON

CCS-Partner Prevention Research Grant panel

LOI review teleconference: April 29, 2014

Panel meeting: September 30, 2014

Richard (Dick) Clayton, PhD (Chair)  University of Kentucky
Lexington, KY, USA
Tracie Barnett, PhD  University of Montreal
Montreal, QC 
Ulrike (Uli) Boehmer, PhD  Boston University
Boston, MA, USA 
Anne Leis, PhD University of Saskatchewan
Saskatoon, SK
S. Elizabeth McGregor, PhD  Alberta Health Services
Calgary, AB 
Annette Schultz, PhD/RN  University of Manitoba
Winnipeg, MB 
Siobhan Sutcliffe, PhD  Washington University School of Medicine
St. Louis, MO, USA
Shelley Tworoger, PhD  Harvard University
Boston, MA, USA 
Melanie Keats, PhD (Scientific Officer) Dalhousie University
Halifax, NS 
Sylvie Poissant (End User)  Canadian Cancer Society - Quebec Division
Montreal, QC
Anne McTiernan-Gamble (End User)  Canadian Cancer Society - New Brunswick Division
Saint John, NB
Julie Stratton (End User)  Region of Peel, Public Health
Mississauga, ON

Career Development Awards in Prevention panel

Panel meeting: June 14, 2016

Julia Knight, PhD (Chair)  Mount Sinai Hospital
Toronto, ON
Joan L. Bottorff, PhD/RN University of British Columbia Okanagan
Kelowna, BC
Sean Cleary, MD Mount Sinai Hospital
Toronto, ON
Katherine Frohlich, PhD University of Montreal
Montreal, QC
Sam Harper, MSPH/PhD McGill University
Montreal, QC
Rayjean Hung, PhD Mount Sinai Hospital
Toronto, ON
Young-in Kim, MD University of Toronto
Toronto, ON
Joanne Kotsopoulos, PhD Women’s College Hospital
Toronto, ON
Jennifer Yessis, PhD University of Waterloo
Waterloo, ON

Quality of Life Grant panel

LOI review teleconference: September 18, 2015

Panel meeting: January 14, 2016

Jamie Studts, PhD (Chair) University of Kentucky
Lexington, KY
Natasha Leighl, MD (Chair) Princess Margaret Cancer Centre
Toronto, ON
*Cristina Caperchione, PhD University of British Columbia (Okanagan)
Kelowna, BC
Anees Chagpar, MD Yale University
New Haven, CT
S. Robin Cohen, PhD McGill University
Montreal, QC 
Kristine Donovan, PhD/MBA  Moffitt Cancer Center and Research Institute
Tampa, FL
David Eisenstat, MD University of Alberta
Edmonton, AB 
Sophie Lebel, PhD University of Ottawa
Ottawa, ON
Christopher Longo, PhD McMaster University
Hamilton, ON
*Donald Mabbott, PhD The Hospital for Sick Children
Toronto, ON
*Christine Maheu, PhD McGill University
Montreal, QC 
Suzanne O’Neill, PhD Georgetown University
Washington, DC
Dean Regier, PhD  BC Cancer Agency
Vancouver, BC 
*Tara Schapmire, PhD  University of Louisville
Louisville, KY
*Allen Sherman, PhD  University of Arkansas
Little Rock, AR 
Marcy Winget, PhD Stanford University
Stanford, CA 
Rebecca Wong, MD  Princess Margaret Cancer Centre
Toronto, ON
James Wright, MD Juravinski Cancer Centre
Hamilton, ON 
*Eitan Amir, MD/PhD (Scientific Officer) Princess Margaret Cancer Centre
Toronto, ON 
Lauren Walker, PhD (Scientific Officer) Tom Baker Cancer Centre
Calgary, AB
Ryan Normore (Community Representative) Canadian Cancer Society - Nova Scotia Division
Cindy Vinall (Community Representative) Canadian Cancer Society - Ontario Division

Knowledge to Action Grant panel

Panel meeting: June 20, 2016

David Chambers, PhD (Chair)  National Cancer Institute
Rockville, MD
Smita Banerjee, PhD Memorial Sloan-Kettering Cancer Center
New York, NY 
Arminee Kazanjian, PhD University of British Columbia
Vancouver, BC
Martine Puts, RN/PhD University of Toronto
Toronto, ON
Barbara Riley, PhD University of Waterloo
Waterloo, ON
Brenda Sabo, RN/PhD Dalhousie University
Halifax, NS
Adena Scheer, MD St. Michael's Hospital
Toronto, ON
Marko Simunovic, MD/MPH Juravinski Cancer Centre
Hamilton, ON
Kelli Stajduhar, RN/PhD University of Victoria
Victoria, BC
Sharon Straus, MD University of Toronto
Toronto, ON 
Aisha Lofters, MD/PhD (Scientific Officer) St Michael’s Hospital
Toronto, ON
Jessie-Lee McIsaac, PhD (Scientific Officer)
Dalhousie University
Halifax, NS
Bryanna Baker (Community Representative) 
Canadian Cancer Society - British Columbia/Yukon Division
Ryan Normore (Community Representative) 
Canadian Cancer Society - Nova Scotia Division
Ontario Institute for Cancer Research
Toronto, ON
Ontario Institute for Cancer Research
Toronto, ON

Last modified on: April 29, 2016